Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

Hi 2da, I just listened to the CC and Harvey sounded downright giddy, lol. I mean its been years since he's done one of these conferences and wasn't scrambling to raise more capital.

Based on Harvey's comments today (and on the ASCO results), it sure sounds like Merck will be starting a luminal B breast cancer trial with ridaforolimus and Merck's IGF-1R antibody, dalotuzumab. I'm looking for that news along with FDA approval for the AP534 registration trial soon.

By the way has anyone been following the ZIOP sarcoma trial. A review of their ASCO abstracts indicates that the chemo only arm had a PFS of 4.4 months (just under 18 weeks). While it's an apples-oranges situation, I was just wondering if any had any thoughts?

Don